(Q39702859)

14 September 2017

title

The changing face of Hodgkin's disease (English)

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)90631-4

30 April 2022

A. C. Aisenberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A117707

30 April 2022

R. M. Linggood

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A117707

30 April 2022

R. A. Lew

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A117707

30 April 2022

language of work or name

English

0 references

1 December 1979

1 reference

full work available at URL

14 September 2017

https://api.elsevier.com/content/article/PII:0002934379906314?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)90631-4

https://api.elsevier.com/content/article/PII:0002934379906314?httpAccept=text/plain

30 April 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)90631-4

American Journal of Medicine

30 April 2022

published in

1 reference

14 September 2017

volume

67

1 reference

14 September 2017

issue

6

1 reference

14 September 2017

page(s)

921-928

1 reference

The Staging and Treatment of Hodgkin's Disease

14 September 2017

cites work

1

299

1228

The staging and treatment of Hodgkin's disease (English)

Aisenberg

1978

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)90631-4

The management of Hodgkin's disease

30 April 2022

2

299

1246

The management of Hodgkin's disease (English)

Rosenborg

1978

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)90631-4

The chemotherapy of Hodgkin's disease: past experiences and future directions

30 April 2022

3

42

979

The chemotherapy of Hodgkin's disease (English)

DeVita

1978

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)90631-4

Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP

30 April 2022

6

36

252

Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP (English)

Bonadonna

1975

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)90631-4

Abdominal involvement at the onset of Hodgkin's disease.

30 April 2022

10

57

870

Abdominal involvement at the onset of Hodgkin's disease (English)

Aisenberg

1974

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)90631-4

The therapeutic implications of splenic involvement in stage IIIA Hodgkin's disease

30 April 2022

13

39

2158

The therapeutic implications of splenic involvement in stage IIIA Hodgkin's disease (English)

Levi

1977

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)90631-4

The place of radiation therapy in the treatment of Hodgkin's disease

30 April 2022

Radiotherapy results for nodular sclerosing Hodgkin's disease after clinical staging

14

volume

42

0 references

15

39

1439

Radiotherapy results for nodular sclerosing Hodgkin's disease after clinical staging (English)

Johnson

1977

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)90631-4

Initial relapses in previously treated Hodgkin's disease. I. Results of second treatment

30 April 2022

16

37

2840

Initial relapses in previously treated Hodgkin's disease: results of second treatment (English)

Weller

1976

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)90631-4

New assessment of the prognostic significance of histopathology in Hodgkin's disease for laparotomy-negative stage I and stage II patients

30 April 2022

18

39

2174

New assessment of the prognostic significance of histopathology in Hodgkin's disease for laparotomy-negative stage I and II patients (English)

Fuller

1977

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)90631-4

Mantle irradiation in Hodgkin's disease. An analysis of technique, tumor eradication, and complications

30 April 2022

19

37

2813

Mantle irradiation in Hodgkin's disease: an analysis of technique, tumor eradication, and complications (English)

Carmel

1976

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)90631-4

Patterns of relapse in stages I, II and IIIA Hodgkin's disease: Influence of initial therapy and implications for the future

30 April 2022

20

2

853

Patterns of relapse in stages I, II, and IIIA Hodgkin's disease: influence of initial therapy and implications for the future (English)

Levi

1977

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)90631-4

Combined modality therapy of Hodgkin's disease.A report on the stanford trials

30 April 2022

21

42

991

Combined modality therapy of Hodgkin's disease: a report on the Stanford trials (English)

Rosenberg

1978

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)90631-4

30 April 2022

Cancer Treatment Reports

22

60

1217

Eight-drug combination chemotherapy (MOPP-ABDV) and local radiotherapy for advanced Hodgkin's disease (English)

Case

1976

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)90631-4

Fulminant sepsis after the successful treatment of Hodgkin's disease

30 April 2022

24

62

47

Fulminant sepsis after the successful treatment of Hodgkin's disease (English)

Weitzman

1977

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)90631-4

Impaired Antibody Response to Pneumococcal Vaccine after Treatment for Hodgkin's Disease

30 April 2022

25

299

442

Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease (English)

Siber

1978

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)90631-4

Second malignancies complicating Hodgkin's disease in remission

30 April 2022

26

1

947

Second malignancies complicating Hodgkin's disease in remission (English)

Canellos

1975

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)90631-4

Occurrence of Non-Hodgkin's Lymphoma after Therapy for Hodgkin's Disease

30 April 2022

Report of the Committee on Hodgkin's Disease Staging Classification

27

volume

300

page(s)

452

0 references

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)90631-4

The significance of mediastinal involvement in early stage Hodgkin's disease

30 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)90631-4

Hematologic neoplasia in patients treated for Hodgkin's disease

30 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)90631-4

Improved survival in Hodgkin's disease

30 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)90631-4

30 November 2022

Identifiers

1 reference

14 September 2017

1 reference